Working… Menu
Trial record 73 of 2100 for:    cancer vaccine

An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02140138
Recruitment Status : Terminated (Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for administrative reasons.)
First Posted : May 16, 2014
Last Update Posted : June 13, 2016
Information provided by (Responsible Party):
CureVac AG

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 2016
Actual Study Completion Date : April 2016